WELDON STEVEN W (CFO) sold 33.5% of their position (2.27M shares) of GT BIOPHARMA, INC. on the open market
Open‑market sale worth $2.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/14/2020ACC: 0000939798-20-000006
DirectorOfficer10% Owner· CFO
Since Aug 2019
-2.27M
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.27M disposed
Non-Derivative Transactions1
common stock
Direct
Shares
−2.27M
Price / share
$0.00
Trade value
$2.27K
% of position
33.5%
5/13/2020
6.77M→4.50M
Total
Net shares
−2.27M
Net value
-$2.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Direct | 5/13/2020 | S · Sale | −2.27M | $0.00 | $2.27K | 33.5% | 6.77M | 4.50M |
| Total | −2.27M | -$2.27K | ||||||
Derivative Transactions0
No derivative transactions reported